Note: the documents on this web site are PDF files. If you do not have a PDF reader, you can download one now.

Product name Product type Date released
Expand Abacavir/Lamivudine Mylan PI 23 May 2018
 
Expand Rydapt CMI 23 May 2018
 
RYDAPT contains the active ingredient midostaurin.
RYDAPT belongs to a group of medicines called protein kinase inhibitors. It is used to treat certain types of white blood cell disorders.
RYDAPT is used to treat:
acute myeloid leukemia (AML) in adults who have a defect in a gene called FLT3. AML is a type of cancer of white blood cells. White blood cells usually help the body to fight infections, and in the case of AML, the body produces too many abnormal white blood cells (named "myeloid" cells).
a disease called advanced systemic mastocystosis in adults. This is a disorder in which the body produces too many mast cells, a type of white blood cell. Symptoms are caused when too many mast cells get into organs like the liver, bone marrow and spleen, or release substances like histamine into the blood.
RYDAPT works by blocking the action of some enzymes (kinases) of the abnormal cells and stops their division and growth. At the start of the treatment in AML, RYDAPT is always used together with other chemotherapies.
Ask your doctor if you have any questions about why this medicine has been prescribed for you.
Your doctor may have prescribed it for another reason.
This medicine is not addictive.
This medicine is available only with a doctor's prescription.
read more
Expand Rydapt PI 23 May 2018
 
Expand Abacavir/Lamivudine Mylan CMI 23 May 2018
 
ABACAVIR/LAMIVUDINE MYLAN tablets contain abacavir and lamivudine which belong to a group of medicines called antiretrovirals.
These are also available as separate medicinal products.
ABACAVIR/LAMIVUDINE MYLAN tablets are used together with other antiretrovirals to slow down the progression of human immunodeficiency virus (HIV) infection, which can lead to Acquired Immune Deficiency Syndrome (AIDS) and other related illnesses (e.g. AIDS-related Complex or ARC).
ABACAVIR/LAMIVUDINE MYLAN tablets do not cure AIDS or kill the HIV virus, but delays further damage to the immune system by stopping production of new viruses.
ABACAVIR/LAMIVUDINE MYLAN tablets do not reduce the risk of passing the infection to others. You will still be able to pass on the HIV virus by sexual activity or by contamination with infected blood. You should still use proper precautions to prevent this.
While taking ABACAVIR/LAMIVUDINE MYLAN tablets and/or any other therapy for HIV disease, you may continue to develop other infections and other complications of HIV infection. You should keep in regular contact with the doctor who is looking after you.
ABACAVIR/LAMIVUDINE MYLAN tablets are not addictive.
read more
Expand Everolimus Sandoz CMI 18 May 2018
 
EVEROLIMUS SANDOZ is used in the treatment of renal cell carcinoma, a type of kidney cancer; neuroendocrine tumours (NETs), a type of cancer located in the stomach and intestine, lung or pancreas; tuberous sclerosis complex (TSC) with angiomyolipoma of the kidney (a kidney tumour) not requiring immediate surgery; or TSC with subependymal giant cell astrocytoma (sometimes called 'SEGA'), a specific type of brain tumour not requiring immediate surgery.
EVEROLIMUS SANDOZ is also used in the treatment of hormone receptor-positive HER2 negative advanced breast cancer in postmenopausal women, in conjunction with exemestane after failure of letrozole or anastrozole.
It is only used in patients whose tumour has tested negative to HER2.
Everolimus is the active substance in EVEROLIMUS SANDOZ.
Treatment of kidney cancer
EVEROLIMUS SANDOZ stops the cancer from making new cells and cuts off the blood supply. This slows the growth and spread of the cancer.
Treatment of NETs
EVEROLIMUS SANDOZ is used to control the growth of these tumours located in the stomach and intestine, lung or pancreas.
Treatment of SEGA
EVEROLIMUS SANDOZ reduces the size of brain tumours (SEGA) that are caused by a genetic disorder called tuberous sclerosis. This may stop the tumours from causing problems as they grow, such as hydrocephalus (excessive accumulation of fluid within the brain).
Treatment of TSC with angiomyolipoma of the kidney
EVEROLIMUS SANDOZ may reduce the size of angiomyolipoma of the kidney that is associated with a genetic disorder called TSC. This may lower the risk of the tumour(s) causing bleeding complications and may help to preserve kidney function.
Treatment of hormone receptor-positive, HER2 negative advanced breast cancer
Growth of this type of breast cancer is stimulated by oestrogens which are female sex hormones. Oestrogen inhibitors such as letrozole, anastrozole and exemestane reduce the amount of oestrogen and can slow the growth of breast cancers. After failure of letrozole or anastrozole, exemestane is used in combination with EVEROLIMUS SANDOZ to prevent the breast cancer cells from becoming resistant to the exemestane.
The medicine is started by a specialist doctor experienced in tumour treatments.
Ask your doctor if you have any questions about why this medicine has been prescribed for you.
Your doctor may have prescribed it for another reason.
EVEROLIMUS SANDOZ is available only with a doctor's prescription and is not addictive.
Children and adolescents
EVEROLIMUS SANDOZ is not to be used in children or adolescents for the treatment of hormone receptor-positive, HER2 negative advanced breast cancer, advanced neuroendocrine tumours or advanced kidney cancer.
EVEROLIMUS SANDOZ is not to be used in children less than 1 years of age for treatment of SEGA associated with TSC.
read more
Expand Cosopt Preservative Free Eye Drops CMI 17 May 2018
 
COSOPT-Preservative Free is used to lower raised pressure in the eye and to treat glaucoma for patients who might be sensitive to preservative-containing formulations or for whom the use of a preservative free formulation is otherwise advisable. Glaucoma is a condition in which the pressure of fluid in the eye may be high. However, some people with glaucoma may have normal eye pressure. Also, some people with raised eye pressure may not have glaucoma.
Glaucoma is usually caused by a build up of the fluid which flows through the eye. This build up occurs because the fluid drains out of your eye more slowly than it is being pumped in. Since new fluid continues to enter the eye, joining the fluid already there, the pressure continues to rise. This raised pressure may damage the back of the eye resulting in gradual loss of sight. Damage can progress so slowly that the person is not aware of this gradual loss of sight. Sometimes even normal eye pressure is associated with damage to the back of the eye.
There are usually no symptoms of glaucoma. The only way of knowing that you have glaucoma is to have your eye pressure, optic nerve and visual field checked by an eye specialist or optometrist. If glaucoma is not treated it can lead to serious problems. You may have no symptoms but eventually glaucoma can lead to total blindness. In fact, untreated glaucoma is one of the most common causes of blindness.
Although COSOPT-Preservative Free helps control your glaucoma it does not cure it.
For more information about glaucoma, contact Glaucoma Australia (PO Box 420, Crows Nest 1585, telephone 1800 500 880).
COSOPT-Preservative Free contains two active ingredients, dorzolamide hydrochloride and timolol maleate. Both of these active ingredients lower pressure in the eye by reducing the production of fluid, but they do this in different ways.
Dorzolamide hydrochloride belongs to a family of medicines called carbonic anhydrase inhibitors. Timolol maleate belongs to a family of medicines called beta-blockers.
COSOPT-Preservative Free is not addictive.
read more
Expand Everolimus Sandoz PI 17 May 2018
 
Expand Cosopt Preservative Free Eye Drops PI 16 May 2018
 
Expand Panadol Cold & Flu Night Relief PE PI 09 May 2018
 
Expand Panadol Allergy Sinus PI 09 May 2018
 
Expand Zovirax Duo PI 08 May 2018
 
Expand Zovirax Cream PI 08 May 2018
 
Expand Nicabate Minis PI 08 May 2018
 
Expand Lamisil Once PI 08 May 2018
 
Expand Eurax Cream PI 08 May 2018
 
Expand Kloxema cream PI 08 May 2018
 
Expand Kloxema cream CMI 08 May 2018
 
The name of your medicine is Kloxema cream. It contains the active ingredient Clobetasone butyrate at 0.05% w/w as the active ingredient.
Clobetasone butyrate belongs to the group of medicines called corticosteroids. It is used topically to control inflammation of the skin.
Kloxema cream is used to treat eczema and dermatitis, and can help to control patches of dry, red, itchy, flaky or inflamed skin caused by eczema or dermatitis.
Kloxema cream works to stop the skin's over-reaction to the triggers that cause skin flare ups. Kloxema cream suppresses the inflammation that causes eczema or dermatitis, and also has moisturising properties.
Your doctor or pharmacist, however, may have prescribed Kloxema cream for another purpose, so it is important to ask them any questions you have about why this medicine has been recommended for you.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Bavencio CMI 03 May 2018
 
BAVENCIO contains the active substance avelumab, a monoclonal antibody, which is a protein designed to recognise and attach to a specific target in the body protein that helps the immune system to attack and destroy cancer cells.
BAVENCIO is used to treat a rare type of skin cancer called metastatic Merkel Cell Carcinoma (mMCC) whose disease has spread.
This medicine is available only with a doctor's prescription.
BAVENCIO will be given to you in hospital under the supervision of an experienced doctor.
Ask your doctor if you have any questions about why BAVENCIO has been prescribed for you.

Use in Children

The effectiveness of BAVENCIO in children under the age of 12 years has not been established.
read more
  • Download PDF Standard Print
  • Download PDF Large Print
Expand Bavencio PI 03 May 2018
 
Expand Mavenclad PI 02 May 2018